Jubilant Ingrevia Limited (JUBLINGREA.NS)
INR 800.95
(-4.21%)
INR 800.95
(-4.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 2.93 Billion INR | -35.84% |
| 2022 | 4.44 Billion INR | -39.5% |
| 2021 | 7.34 Billion INR | 646.01% |
| 2020 | 984.02 Million INR | 59378.31% |
| 2019 | -1.66 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 849.7 Million INR | 20.27% |
| 2024 Q1 | 706.5 Million INR | 27.25% |
| 2023 Q2 | 923.9 Million INR | 9.53% |
| 2023 FY | 2.84 Billion INR | -35.84% |
| 2023 Q4 | 555.2 Million INR | -20.84% |
| 2023 Q3 | 701.4 Million INR | -24.08% |
| 2023 Q1 | 843.5 Million INR | 3.85% |
| 2022 Q2 | 1.29 Billion INR | 17.95% |
| 2022 Q1 | 1.09 Billion INR | -20.12% |
| 2022 FY | 4.44 Billion INR | -39.5% |
| 2022 Q4 | 812.2 Million INR | -36.69% |
| 2022 Q3 | 1.28 Billion INR | -0.69% |
| 2021 FY | 7.34 Billion INR | 646.01% |
| 2021 Q4 | 1.37 Billion INR | -24.82% |
| 2021 Q3 | 1.82 Billion INR | 10.71% |
| 2021 Q2 | 1.64 Billion INR | -14.08% |
| 2021 Q1 | 1.91 Billion INR | 101.67% |
| 2020 Q4 | 950.65 Million INR | 181.86% |
| 2020 Q3 | -1.16 Billion INR | -144.35% |
| 2020 Q2 | 2.61 Billion INR | 0.0% |
| 2020 FY | 984.02 Million INR | 59378.31% |
| 2019 FY | -1.66 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Biocon Limited | 50.83 Billion INR | 94.216% |
| Blue Jet Healthcare Limited | 3.37 Billion INR | 12.819% |
| Concord Biotech Limited | 6.26 Billion INR | 53.05% |
| Dishman Carbogen Amcis Limited | -413 Million INR | 811.852% |
| Lyka Labs Limited | 29.13 Million INR | -9992.516% |
| Panacea Biotec Limited | - INR | -Infinity% |
| Piramal Pharma Limited | 4.31 Billion INR | 31.868% |
| SMS Lifesciences India Limited | 359.47 Million INR | -717.852% |
| Supriya Lifescience Limited | 1.57 Billion INR | -87.061% |
| Syngene International Limited | 6.46 Billion INR | 54.546% |
| TAKE Solutions Limited | -213.49 Million INR | 1477.09% |
| Zota Health Care Limited | -129.79 Million INR | 2365.054% |